Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(8):601; doi:10.1093/jnci/92.8.601
© 2000 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 8, 601, April 19, 2000
© 2000 Oxford University Press


NEWS

Awards, Appointments, Announcements

Dennis Slamon, M.D., director of the Women’s Cancer Research Program at the University of California at Los Angeles Jonsson Comprehensive Cancer Center, was the co-recipient of the 1999 University of California, San Diego–Salk Institute Translational Medicine Award for his contributions to the field of antibody therapy for human cancer.

Slamon’s research led to the development of the drug Herceptin. Genentech Inc., San Francisco, the manufacturer of Herceptin, is the other recipient of the award.

Mack Honored

Sen. Connie Mack (R-Fla.) received the Association of Community Cancer Centers’ Annual Achievement Award for Outstanding Contributions to Cancer Care.

Mack has helped make patient access to cancer care, prevention, screening, early detection, patient rights, and cancer research top priorities, said ACCC president Margaret A. Riley.

Koch Prize Awarded

The Robert Koch Prize was recently awarded to Ralph Steinman, M.D., professor and senior physician at The Rockefeller University, New York. Steinman is being honored for his discovery and characterization of dendritic cells.

The Robert Koch Foundation, Bonn, Germany, awards its prize annually to recognize outstanding achievements in basic research on infectious and other widespread diseases.

Duchossois Honored

The Society of Surgical Oncology honored businessman Richard L. Duchossois with the James Ewing Layman Award for his contributions in the fight against cancer.



View larger version (123K):
[in this window]
[in a new window]
 
Richard L. Duchossois

 
The Duchossois Foundation has contributed nearly $25 million to the University of Chicago to build the Duchossois Center for Advanced Medicine, renovate the Hematology/Oncology Section of the Department of Medicine, and provide faculty support.

The award is presented annually to a nonphysician who has made a significant contribution to improving the care of cancer patients.

Duffy Named

President Clinton named Stephen C. Duffy to the National Cancer Advisory Board. Duffy is executive vice president of the American Academy of Facial Plastic and Reconstructive Surgery.

ESMO President Appointed

Maurio Tonato, M.D., professor at the University of Perugia, Italy, recently became president of the European Society for Medical Oncology, Copenhagen.

Tonato’s major clinical interests are chemotherapy of non-small cell lung cancer and supportive care with special emphasis on antiemetic prophylaxis. He will serve as ESMO’s president until 2001.

Becker Joins RPCI

Joanne Lynn Becker, M.D., has joined the faculty of Roswell Park Cancer Institute, Buffalo, N.Y., as the medical director of the Blood Bank and Therapeutic Apheresis Unit and associate chief of laboratory medicine in the Department of Pathology and Laboratory Medicine.



View larger version (114K):
[in this window]
[in a new window]
 
Dr. Joanne Lynn Becker

 
Prior to joining the Roswell Park faculty, Becker was the director of the Blood Bank at the Medical College of Virginia Hospitals, Richmond, Va.

Armitage Named

The University of Nebraska Medical Center, Omaha, recently named James Armitage, M.D., as dean of the UNMC College of Medicine. The appointment was effective April 1.

Armitage has been on the UNMC faculty for the past 18 years and served as chairman of the Department of Internal Medicine for 10 years before stepping down from that position at the end of 1999. Armitage served as president of the American Society of Clinical Oncology in 1996 and is president-elect of the American Society for Blood and Bone Marrow Transplantation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?